Catheter Based Valve and Aortic Surgery
This text provides a comprehensive, state-of-the-art review of catheter based approaches to valve and aortic diseases. The scope encompasses involve all the current and upcoming transcatheter aortic valve technologies as well as mitral, pulmonary an
- PDF / 23,759,289 Bytes
- 349 Pages / 439.43 x 683.15 pts Page_size
- 26 Downloads / 212 Views
Gorav Ailawadi Irving L. Kron Editors
123
Catheter Based Valve and Aortic Surgery
Gorav Ailawadi • Irving L. Kron Editors
Catheter Based Valve and Aortic Surgery
Editors Gorav Ailawadi, MD Chief, Section of Adult Cardiac Surgery Surgical Director Advanced Cardiac Valve Center University of Virginia Department of Surgery Charlottesville, VA, USA
Irving L. Kron, MD Hurt Watts Professor and Chairman University of Virginia Hospital Department of Surgery Charlottesville, VA, USA
ISBN 978-1-4939-3430-0 ISBN 978-1-4939-3432-4 DOI 10.1007/978-1-4939-3432-4
(eBook)
Library of Congress Control Number: 2016933482 Springer New York Heidelberg Dordrecht London © Springer Science+Business Media New York 2016 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, express or implied, with respect to the material contained herein or for any errors or omissions that may have been made. Printed on acid-free paper Springer Science+Business Media LLC New York is part of Springer Science+Business Media (www.springer.com)
Preface
The treatment of cardiac diseases has had several breakthroughs in the last 70 years, starting with the development of the cardiopulmonary bypass machine, as well as artificial valves and ventricular assist devices. The treatment of coronary artery disease dramatically changed when Andreas Gruentzig presented an early experience with catheter-based angioplasty in 1977. Roughly 10 years later, angioplasty was more common than coronary artery bypass grafting. For the last 60+ years, significant valve disease has been primarily treated with surgical repair or replacement. In 2002, Alan Cribier performed the world’s first transcatheter aortic valve replacement, dramatically changing the course of catheterbased valve therapies. Over the last 10 years, multiple studies investigating catheter-based aortic valve replacement, including the PARTNER and CoreValve Pivotal Trials, have led to approval for these devices in high-risk and inoperable patients with severe aortic stenosis. Trials with the MitraClip device have also led to approval in patients with primary mitral pathology at prohibitive risk
